We are live on
!
Find out more
MCM
Manchester Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
22.34%
This Fund
S&P 500
This Quarter
Est. Return
-15.76%
1 Year Est. Return
+22.34%
3 Year Est. Return
+57.67%
5 Year Est. Return
+66.95%
10 Year Est. Return
+238.55%
AUM
$583M
AUM Growth
-$112M
(-16%)
Cap. Flow
-$2.47M
Cap. Flow
% of AUM
-0.42%
Top 10 Holdings %
Top 10 Hldgs %
54.95%
Holding
1,199
New
141
Increased
238
Reduced
275
Closed
240
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T. Rowe Price
TROW
|
+$12.3M |
| 2 |
Vanguard Information Technology ETF
VGT
|
+$7.3M |
| 3 |
Vanguard Morningstar Value ETF
VTV
|
+$4.65M |
| 4 |
Apple
AAPL
|
+$3.73M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$2.34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$9.74M |
| 2 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$5.84M |
| 3 |
Becton Dickinson
BDX
|
+$5.15M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$2.88M |
| 5 |
State Street Blackstone Senior Loan ETF
SRLN
|
+$2.62M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 20.6% |
| 2 | Technology | 10.26% |
| 3 | Financials | 7.71% |
| 4 | Healthcare | 5.01% |
| 5 | Consumer Discretionary | 3.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WBA
476
DELISTED
Walgreens Boots Alliance
WBA
| $11K | ﹤0.01% |
300
-321
| -52% | -$13.8K |
|
477
Zoetis
ZTS
$30.9B
| $11K | ﹤0.01% |
62
-12
| -16% | -$2.08K |
|
478
Bel Fuse Inc Class A
BELFA
$3.29B
| $10K | ﹤0.01% |
+442
| New | +$9.63K |
|
|
BELFB
479
Bel Fuse Inc Class B
BELFB
$4.1B
| $10K | ﹤0.01% |
+622
| New | +$10.1K |
|
480
Clean Harbors
CLH
$16.4B
| $10K | ﹤0.01% |
112
-20
| -15% | -$1.93K |
|
481
Coherent
COHR
$63.6B
| $10K | ﹤0.01% |
198
| – | – |
|
482
Coinbase
COIN
$39.2B
| $10K | ﹤0.01% |
210
+100
| +91% | +$9.52K |
|
483
Cerence
CRNC
$403M
| $10K | ﹤0.01% |
410
+35
| +9% | +$1.05K |
|
484
iShares Select Dividend ETF
DVY
$23.6B
| $10K | ﹤0.01% |
85
-5
| -6% | -$626 |
|
485
EastGroup Properties
EGP
$10.9B
| $10K | ﹤0.01% |
68
| – | – |
|
486
Graco
GGG
$13.5B
| $10K | ﹤0.01% |
166
+34
| +26% | +$2.14K |
|
487
ING
ING
$101B
| $10K | ﹤0.01% |
959
+485
| +102% | +$4.95K |
|
488
Inspire Medical Systems
INSP
$1.73B
| $10K | ﹤0.01% |
56
| – | – |
|
489
IQVIA
IQV
$39.8B
| $10K | ﹤0.01% |
46
| – | – |
|
490
Moderna
MRNA
$23.9B
| $10K | ﹤0.01% |
68
| – | – |
|
491
Celanese
CE
$4.88B
| $9K | ﹤0.01% |
75
-5
| -6% | -$718 |
|
492
CONMED
CNMD
$1.48B
| $9K | ﹤0.01% |
92
-39
| -30% | -$4.68K |
|
493
CrowdStrike
CRWD
$229B
| $9K | ﹤0.01% |
+224
| New | +$10.1K |
|
494
MarineMax
HZO
$1.15B
| $9K | ﹤0.01% |
260
| – | – |
|
495
iShares Biotechnology ETF
IBB
$9.82B
| $9K | ﹤0.01% |
75
| – | – |
|
496
Lumentum
LITE
$63.3B
| $9K | ﹤0.01% |
114
| – | – |
|
497
Nutrien
NTR
$31.6B
| $9K | ﹤0.01% |
110
| – | – |
|
498
Ormat Technologies
ORA
$6.87B
| $9K | ﹤0.01% |
113
-37
| -25% | -$2.92K |
|
499
Silicon Laboratories
SLAB
$7.2B
| $9K | ﹤0.01% |
63
| – | – |
|
500
Synopsys
SNPS
$78.8B
| $9K | ﹤0.01% |
30
| – | – |
|
Similar funds
CGIC
AAM
CL
CPA
GUB
SCM
KLI
WC
Manchester Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Manchester Capital Management held 1,199 positions worth $583M, down 16% from $695M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Manchester Capital Management's Q2 2022 filing shows 141 new, 238 increased, 275 reduced and 240 closed positions. Its largest new stake was iShares MSCI USA Min Vol Factor ETF: 19,400 shares worth $1.36M. The largest sale was Berkshire Hathaway Class B, an estimated $9.74M.
By sector, the portfolio is most concentrated in Industrials at 21% of assets, down from 21% a quarter earlier, followed by Technology and Financials.
- Manchester Capital Management's largest Q2 2022 buy was iShares MSCI USA Min Vol Factor ETF: 19,400 shares worth $1.36M.
- Manchester Capital Management added most to T. Rowe Price in Q2 2022, an estimated $12.3M increase.
- Manchester Capital Management's biggest Q2 2022 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $5.84M.
- Manchester Capital Management fully exited Berkshire Hathaway Class B in Q2 2022, selling an estimated $9.74M.
- Manchester Capital Management's ten largest holdings make up 55% of its $583M portfolio in Q2 2022.
- Manchester Capital Management opened 141 new positions and closed 240 in Q2 2022.
- Manchester Capital Management's portfolio value fell 16% quarter-over-quarter to $583M.
Based on Manchester Capital Management's 13F filing for Q2 2022, filed 10 Aug 2022.